Mezzion Pharma Co., Ltd. Q3 revenue KRW 2.4 billion, operating loss KRW 4.2 billion
AI summary · Not investment advice
Mezion sold KRW 2.4 billion in Q3 and lost KRW 4.2 billion from its main business; sales rose 13.7% from a year earlier and 9.9% from the previous quarter.
Operating profit · 3 months
KRW -4.2 billion
Key facts
- Revenue (3 months)
- KRW 2.4 billion
- Net income (3 months)
- KRW -7.4 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 2.1 billion
- Revenue (year to date)
- KRW 6.6 billion
- Operating profit (prior-year 3 months)
- KRW -4.7 billion
- Operating profit (year to date)
- KRW -13.3 billion
- Net income (prior-year 3 months)
- KRW -5.1 billion
- Net income (year to date)
- KRW -5.1 billion
Commentary
AI commentary · Not investment advice
What happened
Mezion reported its consolidated results for the 3rd quarter (July to September).
In the company's terms
Sales for the 3 months were KRW 2.42 billion. That is 13.7% more than the same 3 months a year earlier (KRW 2.13 billion) and 9.9% more than the previous quarter. Sales for the year so far are KRW 6.64 billion.
What changes for shareholders
Operating profit (profit from the core business) was a loss of KRW 4.21 billion for the 3 months. A year earlier, the same period had a loss of KRW 4.65 billion. The loss for the year so far is KRW 13.31 billion.
Net income (the final profit after taxes and all other items) was a loss of KRW 7.45 billion for the 3 months. The previous quarter had a profit, so this is a swing to a loss. The same period a year earlier had a loss of KRW 5.13 billion. The loss for the year so far is KRW 5.07 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
M